Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announces the completion of its acquisition of LifeLabs from OMERS. The transaction, valued at approximately CAN $1.35 billion (approximately USD $1 billion), including net debt, has received all necessary approvals and is now closed. LifeLabs and its more than 6,500 employees will continue to operate under the LifeLabs brand and with the same management team and headquarters. Quest will provide LifeLabs with new expertise, innovations and resources to strengthen the services provided by LifeLabs.
Read the full article: Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation //
Source: https://www.prnewswire.com/news-releases/quest-diagnostics-completes-acquisition-of-lifelabs-enhancing-access-to-diagnostic-innovation-302230039.html